Tower Semiconductor Sinks 14% in a Week Despite “The Strongest Growth Phase in Our History”
Tower Semiconductor (TSEM) fell 14% last week, largely due to a chip sector selloff triggered by Intel's (INTC) weak forecast. Despite this, Tower reported record Q3 revenue of $526M, up 33%, and issued Q4 guidance above estimates. The company aims for $1.1B annualized run rate in silicon photonics by Q4. Trading at 26x forward earnings, near its 5-year average, analysts see potential.
How this was made
The 30-second read
Why it matters
Tower's strong Q3 results and raised guidance are positive, but the broader chip sell‑off creates short‑term headwinds.
Market read
First‑time disclosure of Tower's Q3 numbers and Q4 outlook makes the article materially relevant for traders targeting semiconductor exposure.
What to watch
Long‑term silicon photonics contracts through 2029 could provide revenue stability beyond the near‑term Intel shock.
Background
The article combines a fresh earnings/ guidance release with a market reaction driven by Intel's forecast, highlighting both company‑specific and sector‑wide dynamics.
Ticker impact
Tower Semiconductor reported record Q3 revenue and raised Q4 guidance, yet its stock fell 14% after Intel's weak forecast.
likely modest downside as market prices in Intel slowdown, though fundamentals remain strong
The article provides fresh revenue and guidance numbers (first disclosure) and notes a recent 14% price drop, giving traders a clear short‑term risk/reward picture.
Market effects
Silicon‑photonic and optical‑chip suppliers may see heightened scrutiny as Intel’s PC slowdown ripples through the sector.
U.S. semiconductor sector likely faces short‑term pressure, while Asian fabs remain less affected.
The news is relevant to global AI‑optics supply chains but limited to Tier‑1 chip makers.
Counterpoint
Despite the sell‑off, the 26x forward earnings multiple is at the five‑year average, suggesting undervaluation.
Key entities
- companyTower Semiconductor
Semiconductor fab focusing on silicon photonics and specialty processes.



